Literature DB >> 30778894

Neuroprotective effect of Mayan medicinal plant extracts against glutamate-induced toxicity.

Cristina M Castillo-Bautista1, Luis W Torres-Tapia1, Jorge A Rangel-Méndez2, Sergio R Peraza-Sánchez1, Daniel Cortés3,4, Iván Velasco3,4, Rosa E Moo-Puc5,6.   

Abstract

Neurological disorders are a public health problem worldwide for which there is currently no direct treatment of the cause of the disorder. The goal of this study was to investigate the potential in vitro neuroprotective property of plants used in Mayan traditional medicine. Plant ethanolic extracts were prepared and tested on models in which neuronal damage was induced by glutamate, i.e., a human neuroblastoma cell line (SH-SY5Y) and rat cortical neurons. HPLC profiles from active extracts were also obtained. A total of 51 plant species were identified in the literature as plant species used in Mayan traditional medicine for the treatment of symptoms suggestive of neurological disorders, and we studied 34 of these in our analysis. Six extracts had a neuroprotective effect on SH-SY5Y cells, with the most active extract being that from Schwenckia americana roots (half maximal effective concentration [EC50] 11.3 ± 2.9 μg/mL), and three extracts exhibited a neuroprotective effect in the rat neuron cortical model, with the most active extract being that from Elytraria imbricata aerial parts (EC50 6.8 ± 3.1 μg/mL). These results suggest that the active extracts from such plants have the potential to be a great resource. Future studies should be performed that are more extensive and which isolate the active constituents.

Entities:  

Keywords:  Glutamate; Mayan traditional medicine; Neuroprotective effect; Rat cortical neuron; SH-SY5Y cell line

Mesh:

Substances:

Year:  2019        PMID: 30778894     DOI: 10.1007/s11418-019-01284-w

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  7 in total

Review 1.  Clinical trials for neuroprotection in Parkinson's disease: overcoming angst and futility?

Authors:  Albert Y Hung; Michael A Schwarzschild
Journal:  Curr Opin Neurol       Date:  2007-08       Impact factor: 5.710

2.  The global burden of neurologic diseases.

Authors:  Jerome H Chin; Nirali Vora
Journal:  Neurology       Date:  2014-07-22       Impact factor: 9.910

3.  Correlation between plasma levels of glutamate, alanine and serine with severity of depression.

Authors:  Hideaki Mitani; Yukihiko Shirayama; Takeshi Yamada; Kazuhisa Maeda; Charles R Ashby; Ryuzou Kawahara
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-05-16       Impact factor: 5.067

4.  Piperidine and tetrahydropyridine alkaloids from Lobelia siphilitica and Hippobroma longiflora.

Authors:  Julie R Kesting; Inge-Lise Tolderlund; Anders F Pedersen; Matthias Witt; Jerzy W Jaroszewski; Dan Staerk
Journal:  J Nat Prod       Date:  2009-02-27       Impact factor: 4.050

5.  Anticonvulsant activity of Mimosa pudica decoction.

Authors:  E Ngo Bum; D L Dawack; M Schmutz; A Rakotonirina; S V Rakotonirina; C Portet; A Jeker; H-R Olpe; P Herrling
Journal:  Fitoterapia       Date:  2004-06       Impact factor: 2.882

6.  In vitro neuroprotective potential of four medicinal plants against rotenone-induced toxicity in SH-SY5Y neuroblastoma cells.

Authors:  Keabetswe Seoposengwe; Jacob John van Tonder; Vanessa Steenkamp
Journal:  BMC Complement Altern Med       Date:  2013-12-12       Impact factor: 3.659

7.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.